Simultaneous electrochemical determination of levodopa and piroxicam using a glassy carbon electrode modified with a ZnO-Pd/CNT nanocomposite.
Hassan Karimi-MalehIran Sheikh ShoaieAli SamadzadehPublished in: RSC advances (2018)
A highly conductive electrochemical sensor was constructed for the simultaneous electrochemical determination of levodopa and piroxicam by modification of a glassy carbon electrode with a ZnO-Pd/CNT nanocomposite (GCE/ZnO-Pd/CNTs). The ZnO-Pd/CNT nanocomposite was synthesized by the sol-gel procedure and was characterized by EDAX, MAP and SEM. The sensor was shown to improve the oxidation signal of levodopa and piroxicam by ∼70.2-fold and ∼41.5-fold, respectively. This marks the first time that the electrochemical behavior of levodopa and piroxicam have been investigated at the surface of GCE/ZnO-Pd/CNTs. The voltammogram showed a quasi-reversible signal and an irreversible redox signal for electro-oxidation of levodopa and piroxicam, respectively. The GCE/ZnO-Pd/CNTs showed a linear dynamic range of 0.6 to 100.0 μM (at a potential of ∼180 mV) and 0.1 to 90 μM (at a potential of ∼480 mV) with detection limits of 0.08 and 0.04 μM for the determination of levodopa and piroxicam, respectively. GCE/ZnO-Pd/CNTs were then applied for the determination of levodopa and piroxicam in real samples.
Keyphrases
- reduced graphene oxide
- quantum dots
- parkinson disease
- visible light
- gold nanoparticles
- molecularly imprinted
- deep brain stimulation
- room temperature
- solid phase extraction
- ionic liquid
- carbon nanotubes
- electron transfer
- sensitive detection
- high resolution
- human health
- light emitting
- atomic force microscopy
- climate change